Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis
- PMID: 34223839
- DOI: 10.3791/62373
Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis
Abstract
Zebrafish larval xenografts are being widely used for cancer research to perform in vivo and real-time studies of human cancer. The possibility of rapidly visualizing the response to anti-cancer therapies (chemo, radiotherapy, and biologicals), angiogenesis and metastasis with single cell resolution, places the zebrafish xenograft model as a top choice to develop preclinical studies. The zebrafish larval xenograft assay presents several experimental advantages compared to other models, but probably the most striking is the reduction of size scale and consequently time. This reduction of scale allows single cell imaging, the use of a relatively low number of human cells (compatible with biopsies), medium-high-throughput drug screenings, but most importantly enables a significant reduction of the time of the assay. All these advantages make the zebrafish xenograft assay extremely attractive for future personalized medicine applications. Many zebrafish xenograft protocols have been developed with a wide diversity of human tumors; however, a general and standardized protocol to efficiently generate zebrafish larval xenografts is still lacking. Here we provide a step-by-step protocol, with tips to generate xenografts and guidelines for tumor behavior analysis, whole-mount immunofluorescence, and confocal imaging quantification.
Similar articles
-
Zebrafish Patient-Derived Avatars from Digestive Cancers for Anti-cancer Therapy Screening.Curr Protoc. 2022 Apr;2(4):e415. doi: 10.1002/cpz1.415. Curr Protoc. 2022. PMID: 35436037
-
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.J Vis Exp. 2019 Apr 30;(146). doi: 10.3791/59507. J Vis Exp. 2019. PMID: 31107449
-
Zebrafish Xenografts for the In Vivo Analysis of Healthy and Malignant Human Hematopoietic Cells.Methods Mol Biol. 2019;2017:205-217. doi: 10.1007/978-1-4939-9574-5_16. Methods Mol Biol. 2019. PMID: 31197779
-
Zebrafish Avatar to Develop Precision Breast Cancer Therapies.Anticancer Agents Med Chem. 2022;22(4):748-759. doi: 10.2174/1871520621666210402111634. Anticancer Agents Med Chem. 2022. PMID: 33797388 Review.
-
Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts.NPJ Precis Oncol. 2023 May 18;7(1):44. doi: 10.1038/s41698-023-00386-9. NPJ Precis Oncol. 2023. PMID: 37202469 Free PMC article. Review.
Cited by
-
Establishment of Pancreatobiliary Cancer Zebrafish Avatars for Chemotherapy Screening.Cells. 2021 Aug 13;10(8):2077. doi: 10.3390/cells10082077. Cells. 2021. PMID: 34440847 Free PMC article.
-
Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer.Nat Commun. 2024 Jun 5;15(1):4771. doi: 10.1038/s41467-024-49051-0. Nat Commun. 2024. PMID: 38839755 Free PMC article.
-
A Simple, Rapid, and Effective Method for Tumor Xenotransplantation Analysis in Transparent Zebrafish Embryos.J Vis Exp. 2024 Jul 12;(209):10.3791/66164. doi: 10.3791/66164. J Vis Exp. 2024. PMID: 39072643 Free PMC article.
-
miR-23b-3p, miR-126-3p and GAS5 delivered by extracellular vesicles inhibit breast cancer xenografts in zebrafish.Cell Commun Signal. 2024 Nov 18;22(1):552. doi: 10.1186/s12964-024-01936-9. Cell Commun Signal. 2024. PMID: 39558342 Free PMC article.
-
Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metformin.Front Oncol. 2022 Sep 28;12:862889. doi: 10.3389/fonc.2022.862889. eCollection 2022. Front Oncol. 2022. PMID: 36249066 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical